Scottsdale, ARIZONA4 Active Studies

Myasthenia Gravis Clinical Trials in Scottsdale, ARIZONA

Find 4 actively recruiting myasthenia gravis clinical trials in Scottsdale, ARIZONA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
681
Enrolling

Recruiting Myasthenia Gravis Studies in Scottsdale

RecruitingScottsdale, ARIZONANCT07039916

Study to Access the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

This is a 26-week study to assess the efficacy, safety and tolerability of IMVT-1402 in adult participants with mild to severe generalized myasthenia gravis....

231 participants
Immunovant Sciences GmbH
View Study Details
RecruitingScottsdale, ARIZONANCT06744920

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

A study to evaluate the efficacy, safety and tolerability of Remibrutinib versus placebo in adult patients with Generalized Myasthenia Gravis who are on stable, standard-of-care (SOC) treatment....

180 participants
Novartis Pharmaceuticals
View Study Details
RecruitingScottsdale, ARIZONANCT06517758

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG.

The study is a randomized, double-blind, placebo-controlled, multicenter, Phase III study, to evaluate efficacy, safety and tolerability of iptacopan in patients with AChR+ gMG who are on stable SOC t...

146 participants
Novartis Pharmaceuticals
View Study Details
RecruitingScottsdale, ARIZONANCT06558279

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

The purpose of this study is to evaluate the efficacy and safety of efgartigimod PH20 SC given by a pre-filled syringe in adult patients with ocular myasthenia gravis. The study consists of a part A (...

124 participants
argenx
View Study Details

About Myasthenia Gravis Clinical Trials in Scottsdale

Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles responsible for breathing and movement. It occurs when communication between nerves and muscles is disrupted. Treatment includes medications that improve neuromuscular transmission and immunosuppressive therapies.

There are currently 4 myasthenia gravis clinical trials recruiting participants in Scottsdale, ARIZONA. These studies are seeking a combined 681 participants. Research is being sponsored by Immunovant Sciences GmbH, Novartis Pharmaceuticals, argenx. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myasthenia Gravis Clinical Trials in Scottsdale — FAQ

Are there myasthenia gravis clinical trials in Scottsdale?

Yes, there are 4 myasthenia gravis clinical trials currently recruiting in Scottsdale, ARIZONA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Scottsdale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you about next steps.

Are clinical trials in Scottsdale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Scottsdale studies also compensate for your time and travel.

What myasthenia gravis treatments are being tested?

The 4 active trials in Scottsdale are testing new therapies including novel drugs, biologics, and treatment approaches for myasthenia gravis.

Data updated March 2, 2026 from ClinicalTrials.gov